{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T09:03:30Z","timestamp":1721552610443},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1097\/mbc.0000000000000055","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T20:58:02Z","timestamp":1396040282000},"page":"364-368","source":"Crossref","is-referenced-by-count":9,"title":["Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke"],"prefix":"10.1097","volume":"25","author":[{"given":"Amir-Houshang","family":"Shemirani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1lint","family":"Antalfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Endre","family":"Pongr\u00e1cz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n Andr\u00e1s","family":"Mezei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsuzsanna","family":"Bereczky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"Csiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210203","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1152\/physrev.00016.2010","article-title":"Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.","volume":"91","author":"Muszbek","year":"2011","journal-title":"Physiol Rev"},{"key":"R2-13-20210203","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-0030-1248721","article-title":"Factor XIII and atherothrombotic diseases.","volume":"36","author":"Muszbek","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"R3-13-20210203","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/187152508784871990","article-title":"The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis.","volume":"6","author":"Muszbek","year":"2008","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"R4-13-20210203","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood.V84.2.517.517","article-title":"Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels.","volume":"84","author":"Mikkola","year":"1994","journal-title":"Blood"},{"key":"R5-13-20210203","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1055\/s-0037-1614061","article-title":"Deficiency causing mutations and common polymorphisms in the factor XIII-A gene.","volume":"84","author":"Muszbek","year":"2000","journal-title":"Thromb Haemost"},{"key":"R6-13-20210203","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0037-1614250","article-title":"Association of a common polymorphism in the factor XIII gene with myocardial infarction.","volume":"79","author":"Kohler","year":"1998","journal-title":"Thromb Haemost"},{"key":"R7-13-20210203","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1160\/TH06-11-0676","article-title":"Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis.","volume":"97","author":"Voko","year":"2007","journal-title":"Thromb Haemost"},{"key":"R8-13-20210203","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.thromres.2011.11.030","article-title":"Lack of evidence for association between factor XIII-A Val34Leu polymorphism and ischemic stroke: a meta-analysis of 8800 subjects.","volume":"130","author":"Li","year":"2011","journal-title":"Thromb Res"},{"key":"R9-13-20210203","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.thromres.2010.06.012","article-title":"Factor XIII A subunit Val34Leu polymorphism in patients suffering atherothrombotic ischemic stroke.","volume":"126","author":"Shemirani","year":"2010","journal-title":"Thromb Res"},{"key":"R10-13-20210203","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1515\/CCLM.2004.142","article-title":"Rapid detection of the factor XIII Val34Leu (163 G--T) polymorphism by real-time PCR using fluorescence resonance energy transfer detection and melting curve analysis.","volume":"42","author":"Shemirani","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"R11-13-20210203","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1055\/s-0037-1614073","article-title":"Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A.","volume":"84","author":"Wartiovaara","year":"2000","journal-title":"Thromb Haemost"},{"key":"R12-13-20210203","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1182\/blood.V96.3.988","article-title":"The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure.","volume":"96","author":"Ariens","year":"2000","journal-title":"Blood"},{"key":"R13-13-20210203","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.bbapap.2006.06.007","article-title":"The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma.","volume":"1764","author":"Shemirani","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"R14-13-20210203","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1055\/s-0037-1614189","article-title":"Effect of factor XIII Val34Leu on alpha2-antiplasmin incorporation into fibrin.","volume":"84","author":"Schroder","year":"2000","journal-title":"Thromb Haemost"},{"key":"R15-13-20210203","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(03)13135-2","article-title":"Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk.","volume":"361","author":"Lim","year":"2003","journal-title":"Lancet"},{"key":"R16-13-20210203","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/01.ATV.20.5.1354","article-title":"Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy.","volume":"20","author":"Collet","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R17-13-20210203","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1161\/01.STR.0000083534.81284.C5","article-title":"Sex differences in management and outcome after stroke: a Swedish national perspective.","volume":"34","author":"Glader","year":"2003","journal-title":"Stroke"},{"key":"R18-13-20210203","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/01.STR.0000068410.07397.D7","article-title":"Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry.","volume":"34","author":"Di Carlo","year":"2003","journal-title":"Stroke"},{"key":"R19-13-20210203","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0049-3848(99)00033-X","article-title":"Fibrinogen and womens health.","volume":"95","author":"Vorster","year":"1999","journal-title":"Thromb Res"},{"key":"R20-13-20210203","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/0002-8703(90)90026-T","article-title":"Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience.","volume":"120","author":"Kannel","year":"1990","journal-title":"Am Heart J"},{"key":"R21-13-20210203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(87)93050-9","article-title":"Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.","volume":"2","author":"Hamsten","year":"1987","journal-title":"Lancet"},{"key":"R22-13-20210203","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1055\/s-0038-1653821","article-title":"Haemostasis factors in angina pectoris; relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study Group.","volume":"73","author":"Haverkate","year":"1995","journal-title":"Thromb Haemost"},{"key":"R23-13-20210203","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1055\/s-0037-1615055","article-title":"Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease.","volume":"79","author":"Ossei-Gerning","year":"1998","journal-title":"Thromb Haemost"},{"key":"R24-13-20210203","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3324\/haematol.10647","article-title":"Elevated factor XIII level and the risk of myocardial infarction in women.","volume":"92","author":"Bereczky","year":"2007","journal-title":"Haematologica"},{"key":"R25-13-20210203","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3324\/haematol.12708","article-title":"Elevated factor XIII level and the risk of peripheral artery disease.","volume":"93","author":"Shemirani","year":"2008","journal-title":"Haematologica"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0000000000000055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:21:28Z","timestamp":1620958888000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201406000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0000000000000055","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}